Posted on 10/6/16
This Looks to Be Johnson & Johnson's Next Blockbuster Drug
JOHNSON & JOHNSON CEO ALEX GORSKY. IMAGE SOURCE: JOHNSON & JOHNSON.Healthcare conglomerate Johnson & Johnson (NYSE:JNJ) probably needs little introduction -- it's a commonly held stock . . .
Posted on 10/5/16
Immunomedics Announces $30 Million Financing
MORRIS PLAINS, N.J., Oct. 05, 2016 (GLOBE NEWSWIRE) -- Immunomedics, Inc., (Nasdaq:IMMU) today announced that it has priced an underwritten offering of 10,000,000 shares of common . . .
Posted on 10/5/16
What Clinton and Trump Would Do to Medicare
Baby boomers are increasingly nervous they won't have enough money to pay for healthcare in retirement, and with Medicare straining because of rising enrollment, it's unlikely . . .
Posted on 10/5/16
Tabula Rasa HealthCare Closes IPO
MOORESTOWN, N.J., Oct. 04, 2016 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations . . .
Posted on 10/5/16
Daiichi Sankyo Announces New Strategic Immuno-Oncology Research Collaboration with AgonOx
Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced today that it has entered into a strategic collaboration with AgonOx, Inc., a privately held biotechnology company developing . . .
Posted on 10/4/16
NJ Spine and Wellness Celebrates with Grand Opening Event at New Freehold Location
FREEHOLD, N.J., Oct. 04, 2016 (GLOBE NEWSWIRE) -- Enjoy live entertainment and a special guest appearance while exploring the new expansive location of NJ Spine and . . .
Posted on 10/4/16
Instant Analysis: Celgene Pays $600 Million for Swiss Biotech
IMAGE SOURCE: CELGENE What happened?Celgene (NASDAQ:CELG) is at it again. The acquisitive company agreed to pay $600 million for Switzerland-based EngMab.Privately held EngMab is a biotech . . .
Posted on 10/4/16
Ember Therapeutics Signs Endorsement Deal with 12 Time Olympic Medalist Ryan Lochte
NEW YORK, Oct. 03, 2016 (GLOBE NEWSWIRE) -- EMBER THERAPEUTICS (OTCQB:EMBT), today announced that Olympic Gold Medalist Ryan Lochte has signed an endorsement agreement with the . . .
Posted on 10/4/16
Healthcare2U Expands into the Northeast
Continuing rapid growth, Healthcare2U is expanding its network of direct primary care clinics into the Northeast.Dr. Lorenzo Galante and Dr. Sanjay K. Aggarwal, of New Haven, . . .
Posted on 10/4/16
Premera Blue Cross and Quartet Partner
SEATTLE & NEW YORK--(BUSINESS WIRE)--Premera Blue Cross, the largest health plan in the Pacific Northwest, andQuartet, a technology company making behavioral healthcare more accessible and integrated . . .
Posted on 10/3/16
Better Buy: GlaxoSmithKline plc vs. Johnson & Johnson
IMAGE SOURCE: JOHNSON & JOHNSON.Many investors gravitate to large-company stocks in the pharmaceutical space because of the combination of growth and reliable dividend income that they . . .
Posted on 10/3/16
Celgene Is Building an Autoimmune Empire -- and No One Is Talking About It
IMAGE SOURCE: PUBLICDOMAINPICTURES.NET.When it comes to Celgene (NASDAQ:CELG), investors' focus has revolved around its megablockbuster Revlimid franchise -- and for good reason. Revlimid, an oral treatment . . .
Posted on 10/3/16
Is Celgene the Smartest Buyer in Biotech?
IMAGE SOURCE: GETTY IMAGES.Celgene (NASDAQ:CELG) is well known for its superstar drugs, including blood-cancer drug Revlimid, which hit $5.8 billion in sales last year and could . . .
Posted on 10/3/16
Hillary Clinton vs. Donald Trump on Obamacare
IMAGE SOURCE: GETTY IMAGES.In a little more than five weeks, American voters will head to the polls to determine who will lead the United States for . . .
Posted on 10/2/16
Delcath Prices Stock Offering
NEW YORK--(BUSINESS WIRE)--Delcath Systems, Inc. (DCTH) an interventional oncology company focused on treatments for primary and metastatic liver cancers, today announced the pricing of an underwritten . . .
Posted on 9/30/16
Bristol-Myers Squibb (BMY) Presents at Leerink Partners Rare Disease & Immuno-Oncology Roundtable Conference (Transcript)
Bristol-Myers Squibb Company (NYSE:BMY)Leerink Partners Rare Disease & Immuno-Oncology Roundtable ConferenceSeptember 29, 2016 03:00 PM ETExecutivesDr. Fouad Namouni - Oncology Development HeadAnalystsSeamus Fernandez - Leerink Swann, . . .
Posted on 9/30/16
Highlighting New York City's Best Fitness Rooms
Start your New Year's resolutions early this year by kicking off a new fitness routine. While finding enough time to fit in regular workouts can feel . . .
Posted on 9/30/16
ContraVir to Receive $1.8 Million Through New Jersey Technology Business Tax Certificate Transfer Program
ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV), a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, today announced that it received preliminary approval for . . .
Posted on 9/29/16
Actinium Prices Stock Offering
NEW YORK, Sept. 29, 2016 (GLOBE NEWSWIRE) -- Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM), a biopharmaceutical Company developing innovative targeted payload immunotherapeutics for the treatment of advanced . . .
Posted on 9/29/16
Pfizer: No Buy Signal After The Dip
At first glance, the multi-month drop in Pfizer (NYSE:PFE) appears to offer an opportunity. After all, the dividend is back to a respectable 3.5%.When reviewing the . . .
Posted on 9/29/16
Johnson & Johnson: Buying The Dips Beats The Drips - Timing Not An Issue
The Dilemma For Fully Invested Dividend Growth InvestorsHere's an interesting passage from a recent article by Seeking Alpha Author Gary Gordon: According to a Wealth-X census, . . .
Posted on 9/29/16
Better Buy: Johnson & Johnson vs. AbbVie
IMAGE SOURCE: GETTY IMAGES.Keeping the world healthy takes a huge amount of effort, and many of the largest companies on the planet have made it their . . .
Posted on 9/29/16
Tabula Rasa HealthCare Prices IPO
Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), a leader in providing patient-specific, data-driven technology and
Posted on 9/28/16
Foamix Pharmaceuticals Prices $57 Million Follow-on Offering of Ordinary Shares
Foamix Pharmaceuticals Ltd. (Nasdaq: FOMX), a clinical stage specialty pharmaceutical company focused on developing and commercializing its proprietary topical foams to address unmet needs in dermatology, today . . .
Posted on 9/28/16
Genoa to Open Its First Integrated Behavioral Health Pharmacy in New York
Genoa, a QoL Healthcare Company (Genoa), announced its first pharmacy in the state of New York with an event today at Family Service League, a social . . .
New York
